Wall St up, S&P tackles key technical level

The investors positioned themselves for the end of the quarter and it makes the U.S stocks to rise and the S&P 500 attempted to hold above a key technical level. At the end of the quarter the money managers have allocated positions and it leads to the advancement of stocks with the S&P up 5.9 percent. The broke through of S&P to 1,330 was mentioned as the resistance point for the stocks. In the three previous attempts the benchmark was unable to hold gains above that mark. Paul Mendelssohn the chief investment strategist at Windham Financial service in charlotte, Vermont said that they are selling the commodities and they are moving back into industrials. He also said that in the final couple of days of the quarter there will a mini market rotation and it is the way in which the window dressing is taking place. The DJI that is the Dow Jones Industrial average gained 0.81 percent or 100.06 points to 12, 379.07. The NASDAQ composite index gained 0.77 percent to 2,778.35. The Standard Poor 500 index gained 0.90 percent or 11.85 points to 1,331.29. According to the separate report the U.S labor market showed further recovery in the month of March because the private sector employer added hobs while planned layoffs fell.
The ADP report on private sector jobs showed 201, 000 jobs being created and the report may not be dependable indicator of the broader hobs report of the government which is due on Friday. This keeps the expectations intact for the report of the labor department. John Canally economist for LPL financial in Boston said that at 200,000 or so that number is not enough to excite the market one way or the other. He said that you need well above to get people worried that the fed is going to tighten and you need well below that to get people worried about the recession. Valeant Pharmaceuticals the Canadian Drug maker made an unsolicited bid to buy Cephalon Inc for $5.7 billion according to the latest deal news. The U.S listed shares of Valeant shot up 10.4 percent to 49 dollars and the stock of Cephalon drive up 28.1 percent to 75.25 dollars the NYSEArca biotech index has been pushed up 3 percent because of the deal. The investors concentrated on adding winning positions and to lead the strength in energy lifted U.S stocks.

By: Teni Sow | Senior Editor at Tambapress.com and Regular Contributor to Presspresser.com

Related posts:

1. New York Stock Exchange opens up in an upbeat Mood
2. What’s Next for Stocks, M&A, and the Dollar?
3. Libyan Conflict Causes The Asian Stocks To Drop Low
4. U.S. applications for unemployment benefits drop to lowest level in 3 years
5. U.S Housing Collapse Exceeds Up To Level Of 2009 Low

Category: Finance